PERRA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 200.593
NA - Nord America 8.345
AS - Asia 4.141
SA - Sud America 620
AF - Africa 154
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 213.877
Nazione #
IT - Italia 198.191
US - Stati Uniti d'America 8.168
SG - Singapore 1.537
CN - Cina 1.319
SE - Svezia 512
DE - Germania 480
BR - Brasile 459
VN - Vietnam 405
UA - Ucraina 322
FI - Finlandia 299
GB - Regno Unito 227
FR - Francia 192
HK - Hong Kong 186
CA - Canada 112
BD - Bangladesh 111
IN - India 86
KR - Corea 78
TR - Turchia 71
NL - Olanda 65
ZA - Sudafrica 55
AR - Argentina 51
PL - Polonia 49
JP - Giappone 47
IQ - Iraq 42
MA - Marocco 42
ES - Italia 40
RU - Federazione Russa 38
ID - Indonesia 37
BE - Belgio 36
MX - Messico 33
AT - Austria 32
CO - Colombia 27
PK - Pakistan 25
EC - Ecuador 22
IE - Irlanda 20
IR - Iran 20
AU - Australia 19
UZ - Uzbekistan 19
VE - Venezuela 18
SA - Arabia Saudita 17
CL - Cile 15
LT - Lituania 15
MY - Malesia 15
JO - Giordania 13
KE - Kenya 13
PH - Filippine 12
TH - Thailandia 12
TW - Taiwan 11
CH - Svizzera 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
IL - Israele 9
PE - Perù 9
AZ - Azerbaigian 8
DZ - Algeria 8
EG - Egitto 8
JM - Giamaica 8
PA - Panama 8
DK - Danimarca 6
KZ - Kazakistan 6
MT - Malta 6
NP - Nepal 6
GE - Georgia 5
LK - Sri Lanka 5
LV - Lettonia 5
MU - Mauritius 5
TN - Tunisia 5
BG - Bulgaria 4
CR - Costa Rica 4
ET - Etiopia 4
EU - Europa 4
HN - Honduras 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NG - Nigeria 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
EE - Estonia 2
MK - Macedonia 2
NO - Norvegia 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
Totale 213.854
Città #
Cagliari 193.830
Uta 3.615
Ashburn 916
Singapore 900
Fairfield 611
San Jose 584
Dallas 516
Chandler 412
Woodbridge 395
Houston 338
Boardman 333
Nyköping 331
Ann Arbor 261
Los Angeles 261
Beijing 258
Wilmington 246
Seattle 211
Helsinki 202
Cambridge 197
Hong Kong 169
Jacksonville 160
New York 157
Dearborn 156
Munich 150
Council Bluffs 139
Santa Clara 129
The Dalles 121
Ho Chi Minh City 112
Shanghai 111
Hefei 98
Lauterbourg 94
Hanoi 83
Seoul 75
Boston 61
Nanjing 61
Rome 60
Buffalo 55
Chicago 50
Frankfurt am Main 50
São Paulo 49
Milan 48
Guangzhou 47
San Diego 47
Dong Ket 46
London 45
Redwood City 43
Warsaw 39
Orem 37
Toronto 37
Casablanca 35
Redondo Beach 35
Brussels 34
Montreal 34
Atlanta 33
Johannesburg 33
Turku 33
Brooklyn 31
Tokyo 30
Chennai 29
Kocaeli 29
San Mateo 29
Denver 28
Amsterdam 26
Falls Church 26
Nanchang 26
Nuremberg 25
Stockholm 25
Manchester 23
Phoenix 23
Jiaxing 21
Vienna 21
Shenyang 20
Tianjin 20
Mountain View 19
Shenzhen 19
Düsseldorf 18
Rio de Janeiro 18
Da Nang 17
Minneapolis 17
Changsha 16
Dublin 16
Jinan 16
Lappeenranta 16
Paris 16
Tashkent 16
Washington 16
Haiphong 15
Poplar 15
Ankara 14
Augusta 14
Baghdad 14
Bologna 14
Leawood 14
Bari 13
Madrid 13
Norwalk 13
Pisa 13
Biên Hòa 12
Columbus 12
Curitiba 12
Totale 208.023
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.018
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.818
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.977
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.264
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.241
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.055
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.964
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.882
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.760
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.724
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.715
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.663
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.592
Global gene expression profile of normal and regenerating liver in young and old mice 3.568
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.482
Induction of hepatocyte proliferation by retinoic acid 3.322
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.300
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.192
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.176
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.130
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.096
THYROID HORMONE RECEPTORS DOWNREGULATION IS AN EARLY EVENT AND IS MAINTAINED ALLACROSS THE STEP-BY-STEP PROCESS OF HEPATOCARCINOGENESIS 2.994
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.975
Wnt/beta-catenin pathway is activated by thyroid hormone and is required for its hepatomitogenic activity 2.959
ALFA-LIPOIC ACID ENHANCES CHOLINE DEFICIENT DIET-INDUCED FATTY LIVER AND STEATOHEPATITIS, AND PROMOTES THE GROWTH OF PRENEOPLASTIC LESIONS IN RAT LIVER. POSTER EASL 2.929
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.914
Thyroid hormone receptors downregulation is an early event and is maintained all across the step-by-step process of hepatocarcinogenesis. 2.824
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.791
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.769
Progenitor-derived hepatocellular carcinoma model in the rat 2.747
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.743
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.654
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.647
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.637
IMPACT OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS ON PROGRESSION OF HEPATOCELLULAR CARCINOMA 2.602
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.557
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.518
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.481
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 2.465
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.441
Role of natural killercells receptors on the development and progression of hepatocellularcarcinoma 2.419
null 2.399
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.392
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.382
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.332
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.217
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.119
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.025
Cytokeratin-19, a predictive marker and an early determinant of progenitor-derived hepatocellular carcinoma 2.018
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.917
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.788
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.780
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.698
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.671
Early metabolic changes in a liver carcinogenesis model 1.504
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.463
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.452
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.355
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.331
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.236
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.221
Early Metabolic Changes in preneoplastc nodules of the liver 1.180
Hepatic stellate cell: a star cell in the liver 1.125
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 1.100
Non-Invasive Detection of a De Novo Frameshift Variant of STAG2 in a Female Fetus: Escape Genes Influence the Manifestation of X-Linked Diseases in Females 1.071
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 971
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 971
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 932
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 909
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 905
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 876
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 861
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 847
Amoxicillina-acido clavulanico ed anticoagulanti orali:un’associazione potenzialmente pericolosa 830
Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19 829
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 764
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 753
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity 740
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 705
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 675
Inhibitory effect of thyroid hormone (T3) on the development of rat hepatocellular carcinoma. POSTER 661
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 611
Morphological alterations of the lung in the Sickle Cell Trait 606
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration 549
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 543
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 524
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 522
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 485
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 483
Alpha lipoic acid promotes preneoplastic growth in rat liver. POSTER 23° Meeting of German Association for the Study of Liver (GASL), Gottingen 472
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 468
Analysis of pathological findings in a humanized murine model of sickle cell anemia 463
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients 459
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 431
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 429
Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders 413
Morphological investigation of endothelial and sub-endothelial alterations associated with sickle cell trait in a mouse model 408
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 380
Electron microscopy investigation of the Townes mouse spleen: an example of Translational Anatomy 367
Totale 211.814
Categoria #
all - tutte 260.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 260.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.351 0 0 0 0 0 0 0 0 0 0 0 1.351
2021/202210.543 1.481 750 419 752 937 661 455 434 1.189 1.105 1.233 1.127
2022/202316.318 1.073 2.121 2.240 1.383 1.260 1.700 902 940 1.116 1.236 1.499 848
2023/202416.202 1.026 678 893 923 1.442 2.416 2.610 1.407 687 990 1.364 1.766
2024/202537.531 11.399 12.112 3.543 3.185 1.523 1.947 2.254 207 332 297 318 414
2025/202610.606 661 513 986 894 891 695 2.831 460 591 1.095 667 322
Totale 214.276